(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






McDonald's, Caterpillar, and Vertex Pharmaceuticals Earnings Due: Key Metrics

  • February 03rd, 2024
  • 166 views

On Monday, February 5, a lineup of companies is poised to disclose their financial performance, featuring:

McDonald's Corporation (NYSE: MCD), the global fast-food giant, is poised to announce its fourth-quarter 2023 financial results before the market opens.

Analysts anticipate an earnings per share (EPS) of $2.82, with revenue expected to reach $6.45 billion. 

$MCD closed at $297.05 on Friday, down $1.03 (0.35%).

Caterpillar Inc. (NYSE: CAT), a leading manufacturer of construction and mining equipment, will unveil its fourth-quarter and full-year 2023 financial results prior to the stock market opening. 

The consensus EPS estimate stands at $4.75, with revenue amounting to $17.1 billion. 

On Friday, $CAT closed at $315.09, up $7.40 (2.41%).

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX), a key player in the biopharmaceutical industry, will report its fourth-quarter and full-year 2023 financial results after the financial markets close. 

Analysts forecast an EPS of $4.10, accompanied by revenue totaling $2.51 billion. 

$VRTX closed at $424.68 on Friday, reflecting a decrease of $9.19 (2.12%).

 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)

Social Shares

Post Your Comments


Warning: Undefined array key "hashid" in /var/www/html/subs/visit_counter.php on line 13